Chris Johnson reveals ALS diagnosis during ABC’s Good Morning America appearance

Former NFL running back Chris Johnson announced that he has been diagnosed with ALS, saying he has been battling the disease since a diagnosis last year. Johnson made the announcement in a Monday, June 29 interview on ABC’s Good Morning America, according to Yahoo Sports.

Johnson’s appearance brought the topic to a broad mainstream audience, shifting the conversation from football past to health and long-term care. ALS, also known as amyotrophic lateral sclerosis, is a progressive neurological condition that affects nerve cells and can eventually impact mobility, speech, and other functions over time.

In the report, Johnson is described as a former NFL player and a former Tennessee Titans running back, with the diagnosis presented as the central new development. The timing of the announcement, delivered on a major morning program, underscores how former athletes sometimes use public platforms to explain their situation directly rather than leaving fans to infer details.

The announcement also lands in a sports culture that has increasingly emphasized awareness of serious illnesses beyond the usual injury cycle. For NFL observers, the move is a reminder that the league’s public footprint extends well beyond the playing field, particularly for former players whose post-career lives can involve medical realities that are not visible in game-day coverage.

While the report confirms that Johnson has been battling ALS since last year, it does not provide additional medical specifics in the text available here. Readers should treat the announcement as an initial public statement rather than a detailed update on prognosis or treatment.

What to watch next is whether Johnson’s public communications expand to include support organizations, advocacy efforts, or additional clarifications over the coming weeks. For the Titans and NFL community, the announcement is likely to prompt renewed attention to ALS fundraising and education, areas that often gain momentum when high-profile figures go public with personal diagnoses.